Dry Eye Syndrome

News Dry Eye Syndrome

• Provence Technologies and Neuroptis Biotech partner to develop a new compound for treating dry eye syndrome

  Provence Technologies announced the further strengthening of their collaboration for transferring the chemical development of Neuroptis Biotech’s drug candidate, ML7, and producing the first GMP batches before the end of 2012. ML7 is a drug candidate for the treatment of dry eye syndromes. It is the more

• Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG

  Alcon announced that it has entered into a definitive agreement to acquire ESBATech AG. Alcon will pay ESBATech shareholders $150 million in cash at closing, plus contingent payments of up to $439 million based upon the achievement of future research and development milestones that would be expecte more

• Novagali Pharma completes second financing round of 14.2 million euros

  Evry, France. Novagali Pharma, a drug delivery specialist using cationic emulsions to address ophthalmic and other applications including oncology, announces today the completion of its second round of financing. The total amount raised is EUR 14.2 million. New investors Edmond de Rothschild Invest more

Publications Dry Eye Syndrome

• TearLab® Osmolarity System for diagnosing dry eye

  Dry eye (DE) disease is an impairment of the lachrymal unit function and one the most frequent eye problems. A major challenge is to find accurate diagnostic criteria to be able to define DE severity, as symptoms poorly correlate with clinical signs. Tear osmolarity is considered a key factor in DE more

• Design of a superior cytokine antagonist for topical ophthalmic use [Cell Biology]

  IL-1 is a key inflammatory and immune mediator in many diseases, including dry-eye disease, and its inhibition is clinically efficacious in rheumatoid arthritis and cryopyrin-associated periodic syndromes. To treat ocular surface disease with a topical biotherapeutic, the uniqueness of the site nece more

• Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients

  Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients Eye 26, 1602 (December 2012). doi:10.1038/eye.2012.229 Authors: U E Altiparmak, D E Acar, P A Ozer, S D Emec, R Kasim, H Ustun & S Duman more

Market studies Dry Eye Syndrome

• Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2012

  Introduction GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2012" provides data on the Keratoconjunctivitis sicca (Dry Eye) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on K more

• Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Keratoconjunctivitis sicca (Dry Eye), complete with latest upd more

• Diquas (Dry Eye Syndrome) – Analysis and Forecasts to 2022

  Introduction GlobalData’s pharmaceuticals report, “Diquas (Dry Eye Syndrome) – Analysis and Forecasts to 2022” provides Diquas sales forecasts for Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales perf more

Websites Dry Eye Syndrome